Immunoassay standardization: Is it possible, who is responsible, who is capable?

Clinical Chemistry

Volumn 47, Issue 5, 2001, Pages 815-820

  Ulf Hakan S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BIOASSAY; CLINICAL CHEMISTRY; GOOD LABORATORY PRACTICE; HUMAN; IMMUNOASSAY; NOTE; REFERENCE VALUE; RESPONSIBILITY; STANDARDIZATION;

EID: 0035043203     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.5.815     Document Type: Note

References (41)

1. An idea whose time has come
2. Selection of "recommended methods" for use in a clinical laboratory - Some urgent considerations and a suggested approach
3. A reference method laboratory network for cholesterol: A model for standardization and improvement of clinical laboratory measurements
4. Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values
5. Standardization of protein immunoprocedures. Choriogonadotropin (CG)
6. Early screening for ectopic pregnancy in high-risk symptom-free women
7. Reference material for PSA: The IFCC standardization study
8. A model for a comprehensive measurement system in clinical chemistry
9. Analytical specifications of reference methods compilation and critical discussion (from the members of the European EQA-Organizers Working Group B)
10. Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen
11. Three dimensional molecular epitope assignment of monoclonal antibodles (mAb) against hCG and derivatives
12. Standardization of steroid immunoassays - In theory an easy task
13. Immunoassay standardization
14. Role of reference materials in immunoassay standardization
15. Isotope dilution-mass spectrometric quantification of specific proteins: Model application with apolipoprotein A-I
16. Candidate reference methods for hemoglobin A1c based on peptide mapping
17. Isotope dilution-gas chromatography/mass spectrometry and liquid chromatography/electrospray ionization-tandem mass spectrometry for the determination of triiodo-L-thyronine in serum
18. Immunoassay standardisation
19. How much "UFC" is really cortisol?
20. Urinary free cortisol
21. Determination of urinary free cortisol by HPLC
22. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCGβ fragment from standard reference preparations and raw urine samples
23. IFCC Working Group for Standardisation of hCG Measurements: Progress report
24. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
25. Elevation of free β subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease
26. Issues on standardization of immunoassays for prostate-specific antigen: A review
27. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum
28. Discordant results in human chorionic gonadotropin assays
29. Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen
30. Immunochemical mapping of hCG and hCG-related molecules
31. Immunochemical mapping of gonadotropins
32. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: First report from the ISOBM TD-1 workshop
33. Summary report on the ISOBM TD-4 Workshop: Analysis of 56 monoclonal antibodies against the MUC1 mucin, San Diego, CA, November 17-23, 1996
34. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: The ISOBM TD5-1 Workshop
35. New international reference preparation for proteins in human serum (RPPHS)
36. Reference reagents for prostate-specific antigen (PSA): Establishment of the first international standards for free PSA and PSA (90:10)
37. Maternal serum screening for Down's syndrome in early pregnancy
38. Estimation of prostate cancer probability by logistic regression: Free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables
39. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
40. Standardization of steroid hormone assays
41. EQA with accuracy-based kits: Bringing together consensus/reference method targets and method dependent targets